Abstract
The dissolution behavior of nitrofurantoin anhydrate and monohydrate in JP XI, second fluid (pH 6.8) was investigated at various temperatures using a dispersed-amount method and a rotating-disk method. The initial dissolution process of the monohydrate obtained by the rotating-disk method followed the Noyes–Whitney–Nernst equation, but that of the anhydrate did not. The initial dissolution process of the anhydrate was analyzed by a dissolution kinetics equation involving the phase transformation process from anhydrate to monohydrate. The maximal concentration, the dissolution rate constant, and the rate constant of the phase transition process were estimated. The thermodynamic parameters for the dissolution processes of the anhydrate and monohydrate were obtained from van't Hoff plots and Arrhenius plots, respectively. The results of the intrinsic solubility and dissolution parameters of anhydrate and mono-hydrate suggest the possibility that the difference in the dissolution rates of the anhydrate and monohydrate affect the bioavailability of nitrofurantoin preparation. Information on the dissolution behavior of nitrofurantoin pseudopolymorphs is therefore useful for designing high-quality preparations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
L. Leeson and T. Carstensen. Dissolution Technology, American Pharmaceutical Association, Washington, D.C., 1974, Vol. 58, p. 145.
D. E. Cadwallader and H. W. Jun. Nitrofurantoin. Anal. Profiles Drug Subst. 3:346 (1976).
A. E. A. R. Ebian, R. M. A. Moustafa, and E. B. Abul-Enin. Nitrofurantoin. I. Effect of aging at different relative humidities and higher temperatures on the drug release and the physical properties of tablets. Egypt. J. Pharm. Sci. 26:287–300 (1985).
A. E. A. R. Ebian, H. T. Fikrat, R. M. A. Moustafa, and E. B. Abul-Enin. Nitrofurantoin. II. Correlation of in vivo bioavailability to in vitro dissolution of nitrofurantoin tablets aged at different relative humidities and elevated temperatures. Egypt. J. Pharm. Sci. 27:347–358 (1986).
H. W. Gouda, M. A.. Moustafa, and H. I. Al-Shora. Effect of storage on nitrofurantoin solid dosage forms. Int. J. Pharm. 18:213–215 (1984).
H. E. Paul, K. J. Hayes, M. F. Paul, and A. R. Borgmann. Laboratory studies with nitrofurantoin. Relationship between crystal size, urinary excretion in the rat and human, and emesis in dogs. J. Pharm. Sci. 56:882–885 (1967).
I. J. McGilveray, G. L. Mattok, and R. D. Hossie. The comparison of the bioavailabilities of commercial nitrofurantoin tablets. Rev. Can. Biol. 32:99–106 (1973).
P. V. Marshall and P. York. Crystallization solvent induced solid-state and particulate modifications of nitrofurantoin. Int. J. Pharm. 55:257–263 (1989).
M. Otsuka, R. Teraoka, and Y. Matsuda. Characterization of nitrofurantoin anhydrate and monohydrate, and their dissolution behaviors. Chem. Pharm. Bull. 38:833–835 (1990).
T. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:879–885 (1981).
E. Shefter and T. Higuchi. Dissolution behavior of crystalline solvated and nonsolvated forms of some Pharmaceuticals. J. Pharm. Sci. 52:781–791 (1963).
H. Nogami, T. Nagai, and T. Yotsuyanagi. Dissolution phenomena of organic medicinals involving simultaneous phase changes. Chem. Pharm. Bull. 17:499–509 (1969).
H. Nogami, T. Nagai, E. Fukuoka, and T. Yotsuyanagi. Dissolution kinetics of barbital polymorphs. Chem Pharm. Bull. 17:23–31 (1969).
H. Ueda, N. Nambu, and T. Nagai. Dissolution behavior of chlorpropamide polymorphs. Chem. Pharm. Bull. 32:244–250 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Otsuka, M., Teraoka, R. & Matsuda, Y. Rotating-Disk Dissolution Kinetics of Nitrofurantoin Anhydrate and Monohydrate at Various Temperatures. Pharm Res 9, 307–311 (1992). https://doi.org/10.1023/A:1015874415248
Issue Date:
DOI: https://doi.org/10.1023/A:1015874415248